Inventor · disambiguated record
Li Peng
Also filed as: PENG LI · PENG LI VERN
6 granted patents·20 pending applications·31 citations·filing 2010–2025
79Inventor score
Files withPALLEON PHARMACEUTICALS INC14MEDIMMUNE LLC5MEDIMMUNE LTD3INQPHARM GROUP SDN BHD1KINGFA SCIENCE & TECHNOLOGY CO1
Top patents by PatentIndex Score
26 records- 0190US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0287US9527905B2Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of useSELLMAN BRET·Filed 2012·Granted Dec 27, 2016·23 cites·9 claims
- 0381US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 0477US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0572US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 0669US11965188B2Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2019·Granted Apr 23, 2024·1 cites·43 claims
- 0764US11116813B2Antimicrobial garlic compositionsMOOTRAL SA·Filed 2018·Granted Sep 14, 2021·1 cites·20 claims
- 0862US2024344046A1Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0952US2025270325A1Stabilized igg4 antibodies and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 1048US2024067729A1Anti-pd-l1 antibodies and fusion proteins thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1148US2024059773A1Sialidase-pd-1-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1248US2024156979A1Anti-inflammatory siglec proteins and methods of making and using samePALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1347US2023013717A1Polypropylene composition, preparation method and use thereofKINGFA SCIENCE & TECHNOLOGY CO·Filed 2020·Application pending·0 cites
- 1446US2024059792A1Sialidase-her2-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1546US2023265406A1Recombinant sialidases with reduced protease sensitivity, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1645US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 1745US2025049846A1Methods and compositions for treating cancer with immune cellsPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1842US2022372458A1Sialidase-pd-l1-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1942US2022362351A1Recombinant sialidases and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2041US2022387616A1Sialidase-her2-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2141US2022380742A1Sialidase-cd20-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2240US2022356457A1Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2339US2021395333A1Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorderPALLEON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2438US2013035249A1Methods and compositions for detecting and treating cea-expressing cancersMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 2536US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 2626US2019015470A1Garlic compositionsINQPHARM GROUP SDN BHD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Li Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →